Stocks Vision

Company aims to expand its reach with 1000 exclusive store including 250 flagship & 50 global stores at 300 cities across India and abroad.

COMPANY PROFILE :

Our products include men’s ethnic and celebration wear items such as Indo-western, sherwanis, kurtas, jackets and accessories such as jutti, safa, mala, and women’s ethnic and celebration wear items such as lehengas, sarees, stitched suits, gowns and kurtis.

Under the umbrella of Vedant Fashions Limited (formerly known as Vedant Fashions Pvt. Ltd.) and paving the path for a happier family, the brand introduced Mohey, Indian wedding and celebration wear for women, in 2015 and acquired one of the biggest fashion brands in southern India, Mebaz, in 2018, a one-stop heritage brand catering to the entire family, with an established presence in the states of Andhra Pradesh and Telangana.

Timeless and iconic attires have cemented Manyavar’s reputation across the world with a commanding retail presence of 600+ stores in over 200 cities and in 3 countries with 11 international stores in U.A.E & U.S.A.

We believe we have developed a strong brand identity through effective brand advertising with distinct targeted marketing campaigns through a variety of media such as digital and social media, billboards, multiplex cinemas, television, and live events. For such marketing campaigns, our brand ambassadors have included leading individuals from the sporting and film industries.

To share, celebrate and evolve the Manyavar movement. A reflection of Manyavar Ravi Modi’s grit, a global vision and a nurturing spirit, the creative spark of Manya Shilpi Modi, our Chief Visualizer of merchandise and design, together with sales, production and operation groups. Together we are driven by a collective mission: to be an authority in Celebration Wear.

Manyavar envisions leading the category towards a global perspective, beyond cultural and ethnic sensibilities. This means new sections, new products and new concepts for the world citizen.

Creating, enhancing, nurturing, inspiring and ornamenting Respect.

It all began in a 1000 square feet office space with Rs.10,000 as capital. Manyavar was conceptualized in 1999, since then Manyavar has expanded its reach to 200+ cities in India, U.A.E, U.S.A

2007-08 saw the launch of an Exclusive Business Outlet format as Manyavar opens its first EBO outlet outside Kolkata, in Bhubaneshwar.

2010 marked the inauguration of the 100th store in Santa Cruz, Mumbai.

2011 was a highlight with the establishment of Manas Foundation, a non-profit, charitable organization dedicated to support heart surgeries in children.
In the same year, we crossed borders with the opening of our first international store in Dubai, followed by Bangladesh.

2012 Hit the 200 stores mark. India’s largest EBO was inaugurated in Karol Bagh, New Delhi. Manyavar collaborates with Indian Premier Leaugue to partner Kolkata Knight Riders.

2013  we extended our reach to more than 100 cities. The 300th store opened in Quest Mall, Kolkata. Our association with IPL grew stronger with sponsoring Kolkata Knight Riders, Delhi Daredevils, and Sunrisers Hyderabad.

2014 started on a high with the opening of our 333rd store – the grandest Manyavar store in Mumbai. We partnered Indian Super League as Associate Sponsors. Our film advertisements aired across India making us a national brand.

2015 marked the opening of our 400th store in Hazrathanj, Lucknow

2016 will go down in history with the launch of our Women’s Celebration Wear label – Mohey. Launch of EBO in USA

2017 The addition of the brand Mebaz, one stop destination for family celebration wear retail chain across men’s, women’s and kid’s under one roof, accelerating the presence of the company in Southern part of India

2018 We opened our 500th store at Nagpur, Dharampet.

2019 Bollywood actors like Kartik Aryan, Ranveer Singh, and Amitabh Bachchan became the new faces of the brand

2019 Bollywood actress- Alia Bhatt became the brand ambassador of Mohey

2019 Launched 600th store in Mysore.

2019 Launch of our premium men’s wear brand- Twamev

5 countries, 160+ cities, 450+ stores and two new brands in 8 years.
It began as a dream, and the journey continues.

• 2021-Employer Branding Award for “Best Employer Branding Award” hosted by World HRD Congress and Stars Group
• 2021-Retail Award for the “Most Admired Retailer of the year- Marketing and Advertising campaign” granted by Mapic India
• 2020-ET Bengal Corporate Award for “Excellence in Business Performance-Turnover between INR 300 crore and 1,000 crore” granted by Association of Corporate Advisers & Executives, Kolkata and the Economic Times
• 2020-Global Award for Retail Excellence for “Retail Marketing Campaign of the Year #TaiyaarHokarAaiye” granted by ET Now
• 2020-Recognised as India’s Retail Champion (Winner) in Specialty Retail by Bhartiya City Centre
• 2020-Images Excellence Award for “Men’s Indian wear” granted by Images Fashion Awards
• 2019-Global Award for Retail Excellence for the “Retail Marketing Campaign of the Year” granted by ET Now
• 2019- Images Award for “Most Admired Fashion Brand of the year: Men’s Indian wear” granted by Images Fashion Awards
• 2019- Times Business Award for the “Best Men’s Ethnic Wear Brand (East)” granted by the Times Group
• 2019- Dare to Dream Award for “Company of the Year-Retail” granted by Zee Business
• 2019- Indian Retail Award for “Ethnic Fashion Retailer of the Year” granted by Shop X
• 2019 – Transforming India Retail Award for “Transformational Contribution to Indian Apparel and Retail Industry” granted by the Ministry of Textiles and the Clothing Manufacturers Association of India
• 2018 – Images Award for “Most Admired Retailer of the Year Marketing & Promotions Campaign” granted by Images Retail Awards
• 2017 – Images Award for “Most Admired Fashion Brand of the year: Men’s Indian Wear” granted by Images Fashion Awards
• 2016 – Ravi Modi recognized as “Entrepreneur of the Year in Trading Business – Retailer” at the Entrepreneur Awards organized by ET Now and Franchise India
• 2015 – Ravi Modi awarded the “Bravery and Entrepreneur Award” and Certificate of Honor as the “Top Entrepreneur of India” by the Parwaz Media Group
• 2015 – Ravi Modi recognized as “Emerging Leader” at the CMA Management Excellence Awards
• 2015 – ET Bengal Corporate Award for the “Highest Job Creator- Above INR 300 crore to INR 1,000 crore” granted by Association of Corporate Advisers & Executives, Kolkata and the Economic Times
• 2015 – Recognized as the “National Retailer of the Year” at the 4th Annual Indian Retail & Indian e-Retail Awards
• 2015 – Images Award for “Excellence in Supply Chain Management & Fulfillment” granted by Images Retail Tech Awards
• 2014 – Award for Retail Excellence for being the “Pioneer in Ethnic Retail Business” granted by ABP News
• 2014 – ET Bengal Corporate Award for the “Fastest Growing Company-Maximum Turnover of INR 300 crore” granted by Association of Corporate Advisers & Executives, Kolkata and the Economic Times
• 2013 – Ravi Modi awarded for “Retail Excellence” at the Asia Retail Congress organized by ET Now
• 2012 – Ravi Modi awarded the “Young Retailer of the Year” award at the Asia Retail Congress
• 2012 – Ravi Modi awarded the “Jewels of Rajasthan” award presented by Maneesh Media Agency
• 2008-2010 – Recognized as “Iconic Men’s Ethnic Brand” by Central Icons
• 2004-2008 – Recognized as “Best Men’s Ethnic Wear Brand” by Central Icons.

website : https://www.vedantfashions.com/

Brands Under vedant Fashions :

“Manyavar”, “Mohey”, “Mebaz”.

Company has delivered good profit growth of 23.5% CAGR over last 5 years.

Debtor days have improved from 182 to 143 days.

ROCE : Consistently Increasing above 33 % YOY.

Its products include men’s ethnic and celebration wear items such as Indo-western, sherwanis, kurtas, jackets, and accessories such as jutti, safa, mala, and women’s ethnic and celebration wear items such as lehengas, sarees, stitched suits, gowns, and Kurtis.

Omni Channel Network :  Company operates its business through franchise-owned exclusive brand outlets (EBOs), with the remaining by multi-brand outlets (MBOs), large format stores (LFSs), and online platforms, including its website.

Sales through stores – 90%  of FY21 sales was through its exclusive brand outlets (EBOs). It operates through 546 EBOs which are operated on the basis of lease or franchisee, 145 large format stores (LFS), and 825 multi-brand outlets (MBOs). Almost 300 of its EBOs are franchisees in India and 11 EBOs overseas across the United States, Canada, and the UAE.

Online network : It operates through its own website, mobile application, and leading e-commerce platforms. Sales to customers from its online channel rose from Rs. 83m for FY19 to Rs187m in FY21. Also, EBOs can place orders for any products, not in stock and requested by customers; as a result, the company can service customers’ orders at short notice at the EBOs of their choice.

Advertisement: In FY20 company spent 8% of its sales towards advertisement and is one of the sponsors of Kolkata Knight Riders, Delhi Daredevils, and Sunrisers Hyderabad and several Bollywood stars including Kartik Aryan, Ranveer Singh, and Amitabh Bachchan became the new faces of the brand.

The company has built a strong brand identity through effective advertising with targeted marketing campaigns through a variety of formats such as digital and social media, billboards, multiplexes, etc.

Manyavar : (80% of revenues) is their flagship brand, is in the mid-premium Indian wedding and celebration-wear price range with a comprehensive product range.

Twamev : is their premium brand in men’s Indian wedding and celebration wear, is priced between Manyavar and other luxury boutique brands.

Manthan : is their value brand offering Indian wedding and celebration wear clothing for men. Following a refreshed launch in 2018, products are sold primarily through MBOs, LFSs, and online platforms. Management expects to cater to the sizable number of mid-market weddings and other celebrations through this brand.

Mohey : is their mid-premium flagship women’s brand, launched in 2015, and is the largest brand (by number of stores in FY20) across India, focusing on women’s Indian wedding and celebration wear. It offers a range of attires (lehengas, sarees, gowns), aiming to establish a leading position as Manyavar in men’s Indian wedding and celebration wear.

Mebaz : is a established one-stop-shop, heritage brand with a strong legacy, acquired in FY18. In FY21, it was strong in Andhra Pradesh and Telangana.

Product Offerings:  Its products include men’s ethnic and celebration wear items such as Indo-western, sherwanis, kurtas, jackets, and accessories such as jutti, safa, mala, and women’s ethnic and celebration wear items such as lehengas, sarees, stitched suits, gowns, and Kurtis.

Supply Chain : Large portion of manufacturing process is carried out by third-party manufacturers. However, it retains control of manufacturing by ensuring that at various stages of production, incl. design conceptualization and finalization, fabric procurement, work allocation, quality control, testing, and review of the allocation of job orders are managed by it.

Co. has in-house manufacturing processes (cutting, embroidery, stitching, and finishing). It also has ~0.26m sq. ft. central warehouse at Kolkata that houses all its finished products.

Company Name : Vedant Fashions Limited

Cmp : 1431.00 (on 29.10.2022)

52 Weeks High/low : 1502/790.

Target : 2500-4500 ++

Time Frame : 3 Years to 5 Years

Based on Technical Charts

Source of Data :

https://vedantfashions.com/

https://www.screener.in/

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

It’s engaged in manufacturing of Advanced Pharmaceutical Ingredients (APIs), Intermediates and Nutraceutical ingredients with predominance in exports. It has a market presence in 95 countries and 17,000 employees ,31 Years In Industry and is one of the leading pharmaceutical companies in the world.

Divi’s is recognized as a ‘Reliable Supplier of generic APIs (Active pharmaceuticals ingredients)’ and a trustworthy ‘Custom Manufacturer’ to Big Pharma and also is among the top API manufactures in the world.

Divi’s is the leading manufacturer of APIs(Active pharmaceuticals ingredients), Intermediates and Registered starting materials offering high quality products with the highest level of compliance and integrity to over 95 countries.

Divi’s recently reached the milestone of being one among the top 3 API manufacturers in the world and one among the top API companies in Hyderabad.

Divi’s is a Public limited company listed on the Indian stock exchange with a revenue of INR ~7050 crores (~$960M) for the year 2020-21

Advanced manufacturing facilities both in Hyderabad and Vizag have been inspected multiple times by USFDA, EU GMP (UK, Slovenia, German, Irish authorities), HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS health authorities.

We envision creating value for all stakeholders by manufacturing high quality Generic APIs, Custom synthesis of APIs & Intermediates along with Nutraceutical Ingredients to the Global Pharmaceutical & Nutraceutical industry through sustainable leadership in chemistry.

We at Divi’s aim to be a responsible business, adding value through our core competency in the area of chemistry while adhering to our core values and serving the immediate community and at large through our diverse social initiatives that would establish a strong foundation for a better tomorrow for all stakeholders.

The company is engaged in production of leading generic APIs, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global companies.

It has a product portfolio of 122 products across various therapeutic areas.

The company derives 47% of total revenues from top 5 products. Naproxen (an anti-inflammatory drug)

contributed 18% of total sales during FY20. The company is one of the leading suppliers of this drug.

Geographical Revenue Breakup
The company derives 85% of total revenues from exports.
Presently, it earns 47% of revenues from Europe, followed by America (23%), India (15%), Asia (11%) and rest of world (4%).

The revenue share of America has gone down from 33% . In FY17 to 23% in FY20 while the revenue share of Europe has gone up from 40% to 47% in same time frame implicating larger growth from its European Business.

R&D
The company has 3 R&D facilities near its manufacturing locations. These centers are involved in development of processes for both new compounds and improvement of processes for compounds on the market.
It spent ~38 crores towards R&D in FY20 as compared to ~35 crores in FY19.
The cost fluctuates depending on R&D operations, it spent ~43 crores towards R&D in FY17.

Manufacturing Capabilities
The company has 2 manufacturing locations at Bhuvanagiri, Karnataka and Visakhapatnam, Andhra Pradesh. These 2 manufacturing locations houses 6 different manufacturing units with diverse operations.

The company has started construction of its new manufacturing facility in Kakinada, Andhra Pradesh in Dec 2020.
The company will invest 1,500 crores from internal accruals and the operations are likely to commence within 12-18 months for phase-1 of the project.

Subsidiaries
The company has 2 wholly owned subsidiaries
Divis Laboratories (USA) Inc, Europe AG in Switzerland which are engaged in marketing/ distribution of nutraceutical products to provide greater reach to customers within these regions.
The subsidiaries brought 319 crores (6%) of revenues for the company in FY20.

LEADERSHIP :

Our Leadership team includes many members of the Senior Executive team that are well supported by a very diversified team of Board of Directors.

Both the teams are accountable to our shareholders for the responsible conduct of the business and our long-term success. They also represent the interests of all our stakeholders in ensuring that we deliver quality products by putting science at the heart of everything we do.

Leadership team along with the Board of Directors are responsible for the direction, strategy, execution and administration of the company.

The Board comprises of twelve members with Dr. Ramesh B.V. Nimmagadda as Chairman.Under the leadership of Dr. Divi, the Leadership team is responsible for overseeing the business operations. Members of the Leadership team and their biographies are shown below.

Dr. Murali K. Divi (Managing Director)

Dr. Divi is the Founder and Managing Director of Divi’s Laboratories Ltd. Dr. Divi oversees major technical and financial operations of the company.

Prior to starting Divi’s, Dr. Divi had extensive experience of over 15 years in the Pharma industry and has led various Research and Manufacturing teams globally. He holds a Ph.D. degree in Pharmaceutical Sciences from Kakatiya University, India. He is also a member of the American Institute of Chemical Engineers and the American Chemical Society.

Mr. N.V. Ramana

Executive Director

Mr. Nimmagadda is the Executive Director of Divi’s Laboratories Ltd and has been with Divi’s for the past 25 years. In his role, he oversees all functions of Strategic planning, Sales and Marketing, Custom Manufacturing, Contract research and Nutraceutical ingredients development.

Prior to joining Divi’s, Mr. Nimmagadda had over 10 years of experience in the Pharmaceutical industry and was instrumental in enhancing business development for several pharma companies. He is a graduate in chemistry from Osmania University, India. He is also a Member of the American Chemical Society.

Dr. Kiran S. Divi

Whole-Time Director & Chief Executive Officer

Dr. Kiran Divi is the Director on Board & Chief Executive Officer at Divi’s Laboratories Ltd and has been with Divi’s for the past 20 years. He officially took on the role of leading Divi’s as the CEO, starting January 2020. He oversees all the Corporate functions and Operations at our manufacturing facilities. Under his direction, Divi’s has been developing high quality business strategies and plans ensuring their alignment with the short term and long term objectives.

Prior to joining Divi’s, Dr. Divi has gained extensive knowledge and understanding of the Pharmaceutical Industry with an extra focus on the US Generic Market. He has a post-graduate degree in Pharmacy from JNTU, India. He holds a Ph.D. degree from Gandhi Institute of Technology and Management, Visakhapatnam.

Mr. Madhusudana Rao Divi

Whole-Time Director (Projects)

Mr. Rao Divi is the Director of Projects at Divi’s Laboratories Ltd and has been with Divi’s for the past 20 years. He administers all aspects of manufacturing including production, engineering, sustainability and environmental management along with construction of new projects.

Prior to joining Divi’s, Mr. Rao Divi had executed several engineering construction projects and was closely involved in implementing numerous offshore and onshore constructions in India and globally. Mr. Rao Divi has a post-graduate degree in Structural Engineering from Mysore University, India.

Ms. Nilima Prasad Divi

Whole-Time Director (Commercial)

Ms. Nilima is the Director on Board – Commercial at Divi’s Laboratories Ltd and has been with Divi’s for the past 5 years. She administers all aspects of Material Sourcing and Procurement, Corporate Finance and Investor Relations.

Prior to joining Divi’s, Ms. Nilima has gained extensive commercial acumen and familiarity with material requirement planning and financing. Ms. Nilima has a Master’s Degree in International Business from Gitam Institute of Foreign Trade, India and Masters in International Finance from Glasgow University, U.K.

Company Is almost Debt Free .

It Maintains Healthy Dividend Payout Company .

ROCE : 32% in 2021 .

Promoters Holding Is More than 51.95 % .

” In Recent Correction Stock Price is Available at Very Cheap Valuations . If Once Markets Starts Recovering its Will Gain Very Fast . Take Price as Advantage and Buy at per Your Risk “.

If Any New Investors Wants To Open New Demat Account Click on this Link  .

Like Our Facebook Page .

All Information is For Study Purposes Only .

Company Name : DIVI’S LABORATORIES LTD .

CMP : 3941/- ( On 30.01.2022)

Target : Short Term (6 Months to 1 Year ) : 4800 – 5,400/++ .

Long Term (2 – 5 Years of Time Frame ) : 8,500 – 10,300 ++

Based on Technical Charts

Source of Data : https://www.divislabs.com/ & https://www.screener.in/

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

In our Previous Posts We Have Already mentioned about this stock . But again we are Going to Suggest This Stock Due to Its Returns Given in Last 8 Months @ 60 % ++ Returns With In 1 Year.

Click Here for Previous Post .

Stock Trading at 2019 PE at 47.60 Which is Very Cheap and Giving very Good Opportunity For entry .

This Stock is Very Good for Both short Term & Long Term also .

Preferable for Both Short Term & Long Term Investors also .

Company is almost Debt free .

Very Good Dividend Paying Company Year On Year Basis .

ROCE % From Past 10 Years is above 34 % which is Excellent .

Promoters Holding Is More than 74 % .

Risk Free Company – Instead of Buying Less Priced or More Taking More Risk Stock its Better to Buy Such Stock is Better as per My View .

If Any New Investors Wants To Open New Demat Account Click on this Link  .

Like Our Facebook Page .

All Information is For Study Purposes Only .

Company Name : ABBOTT INDIA .

CMP : 16065/-

Best Buy at : 14,900 – 15,800 .

Target : Short Term (6 Months to 1 Year ) – 18,000 – 20,200/++ .

Long Term (2 – 3 Years of Time Frame ) : 22,000 – 24,000 ++

Note : It Will always Gives Good Time to Enter .

Based on Technical Charts

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.